FDA Clearance Tracker · K213705
DRSplus
Last checked: Nov 19, 2026Latest source record: Dec 21, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2021
Substantially Equivalent
Time to decision
27 days
Received Nov 24, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K213705
- Device name
- DRSplus
- Applicant
- Centervue S.P.A.
- Applicant location
- Padova, IT
- Received
- Nov 24, 2021
- Decided
- Dec 21, 2021
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Ophthalmoscope, Laser, Scanning (MYC)
- Device class
- Class II
- Regulation
- 21 CFR 886.1570
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MYC. The earliest in FDA's data is K060424, decided Mar 17, 2006.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K213705
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Centervue S.P.A.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MAIA (AHMACME001)510(k)
K243504 · Decided Mar 17, 2025 · 125 days after receipt
Device type: Ophthalmoscope, Laser, Scanning (MYC) · Ophthalmology
- iCare ALTIUS CW510(k)
K234076 · Decided Aug 22, 2024 · 245 days after receipt
Device type: System, Image Management, Ophthalmic (NFJ) · Radiology & Imaging
K211328 · Decided Aug 19, 2021 · 108 days after receipt
Device type: Ophthalmoscope, Laser, Scanning (MYC) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.